These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22143126)

  • 1. Warfarin resistance associated with parenteral nutrition.
    Cheung LK; Agi R; Hyman DJ
    Am J Med Sci; 2012 Mar; 343(3):255-8. PubMed ID: 22143126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central venous thrombosis in patients receiving long-term parenteral nutrition.
    Duerksen DR
    Appl Physiol Nutr Metab; 2008 Feb; 33(1):32-8. PubMed ID: 18347651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between dietary vitamin K intake and the stability of anticoagulation effect in patients taking long-term warfarin.
    Kim KH; Choi WS; Lee JH; Lee H; Yang DH; Chae SC
    Thromb Haemost; 2010 Oct; 104(4):755-9. PubMed ID: 20664899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid solubility of warfarin may contribute to warfarin resistance in patients receiving total parenteral nutrition.
    McAllister RK; Weinberg GL
    Am J Med Sci; 2012 Oct; 344(4):340. PubMed ID: 22996140
    [No Abstract]   [Full Text] [Related]  

  • 5. Warfarin therapy in children who require long-term total parenteral nutrition.
    Newall F; Barnes C; Savoia H; Campbell J; Monagle P
    Pediatrics; 2003 Nov; 112(5):e386. PubMed ID: 14595081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor correlation of supratherapeutic international normalised ratio and vitamin K-dependent procoagulant factor levels during warfarin therapy.
    Sarode R; Rawal A; Lee R; Shen YM; Frenkel EP
    Br J Haematol; 2006 Mar; 132(5):604-7. PubMed ID: 16445834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials.
    Renda G; di Nicola M; De Caterina R
    Am J Med; 2015 Sep; 128(9):1007-14.e2. PubMed ID: 25910790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin K-independent warfarin resistance after concurrent administration of warfarin and continuous enteral nutrition.
    Dickerson RN; Garmon WM; Kuhl DA; Minard G; Brown RO
    Pharmacotherapy; 2008 Mar; 28(3):308-13. PubMed ID: 18294110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary vitamin K variability affects International Normalized Ratio (INR) coagulation indices.
    Couris R; Tataronis G; McCloskey W; Oertel L; Dallal G; Dwyer J; Blumberg JB
    Int J Vitam Nutr Res; 2006 Mar; 76(2):65-74. PubMed ID: 16941417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of oral anticoagulants (warfarin) in older people. AGS Clinical Practices Committee. American Geriatric Society.
    J Am Geriatr Soc; 2000 Feb; 48(2):224-7. PubMed ID: 10682955
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism.
    Mavrakanas T; Bounameaux H
    Pharmacol Ther; 2011 Apr; 130(1):46-58. PubMed ID: 21185864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep venous thrombosis and pulmonary embolism. Part 2--Prevention of recurrences: warfarin or low-molecular-weight heparin for at least 3 months.
    Prescrire Int; 2013 May; 22(138):129-33. PubMed ID: 23819181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with unstable control have a poorer dietary intake of vitamin K compared to patients with stable control of anticoagulation.
    Sconce E; Khan T; Mason J; Noble F; Wynne H; Kamali F
    Thromb Haemost; 2005 May; 93(5):872-5. PubMed ID: 15886802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the efficacy and rate of response to oral and intravenous Vitamin K in reversal of over-anticoagulation with warfarin.
    Watson HG; Baglin T; Laidlaw SL; Makris M; Preston FE
    Br J Haematol; 2001 Oct; 115(1):145-9. PubMed ID: 11722425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative warfarin reversal for early hip fracture surgery.
    Moores TS; Beaven A; Cattell AE; Baker C; Roberts PJ
    J Orthop Surg (Hong Kong); 2015 Apr; 23(1):33-6. PubMed ID: 25920640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department.
    Anthony CJ; Karim S; Ackroyd-Stolarz S; Fry A; Murphy NG; Christie R; Zed PJ
    Ann Pharmacother; 2011 Jul; 45(7-8):881-7. PubMed ID: 21750309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin K in anticoagulation therapy.
    Hanslik T; Viboud C; Chadenat ML; Jubault V; Prinseau J
    Lancet; 2001 Feb; 357(9256):637; author reply 638. PubMed ID: 11558516
    [No Abstract]   [Full Text] [Related]  

  • 19. When blood is thinner than water.
    Gude D; Abbas A; Mohiuddin H
    Ann Card Anaesth; 2013; 16(1):63-5. PubMed ID: 23287091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral vitamin K produces a normal INR within 24 hours of its administration in most patients discontinuing warfarin.
    Crowther MA; Ageno W; Schnurr T; Manfredi E; Kinnon K; Garcia D; Douketis JD
    Haematologica; 2005 Jan; 90(1):137-9. PubMed ID: 15642685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.